PDCD1LG2 and renal cell carcinoma: In addition, analysis of TCGA datasets revealed that PD-L2 was also expressed in human cancers including GBM and low-grade glioma (LGG)(Supplementary Fig. 1B), lung adenocarcinoma, melanoma, and renal cell carcinoma (Supplementary Fig. 1C).